We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Making Allogeneic Cell Therapy a Reality for Patients: An Interview With Allogene Therapeutics
Industry Insight

Technology Networks spoke with David Chang, MD, PhD, President, Chief Executive Officer and Co-Founder of Allogene to learn about the recent developments in the fast-developing allogeneic cell therapy research space and Allogene's visions for the future.

Read More

Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Industry Insight

Technology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.

Read More

Looking to the Future of Cell and Gene Therapies
Industry Insight

Technology Networks recently spoke with three of the leaders in the cell and gene therapy space, Allogene Therapeutics, bluebird Bio and Mogrify to gain their insights on the next developments in this space.

Read More

Cellular Agriculture – Moving Towards a More Sustainable Method of Milk Production
Industry Insight

As part of efforts to provide a more sustainable method of milk production, TurtleTree Labs has developed a cellular method, which bypasses the environmental and animal welfare issues of industrial dairy. Technology Networks recently spoke with Fengru Lin, the founder of TurtleTree Labs, to learn more about the method and the benefits it could offer.

Read More

High Sensitivity Proteomics: Immunopeptidomics
Industry Insight

Technology Networks recently spoke with Gary Kruppa, PhD, Vice President of Proteomics, Bruker Daltonics Inc., to learn more about the advancing research area immunopeptidomics, and to discuss the current status of single cell proteomics.

Read More

Proteomics Lends a Hand in the Fight Against COVID-19
Industry Insight

Technology Networks spoke with Stephen Williams, Chief Medical Officer of SomaLogic, to learn about how proteomics can contribute to the fight against COVID-19 and the availability of the SomaScan Assay at this critical time.

Read More

How Is COVID-19 Impacting Existing Clinical Trials?
Industry Insight

Technology Networks recently had the pleasure of speaking with Panthera’s CEO Stuart Young to learn more about how the COVID-19 pandemic is impacting existing clinical trials and the guidelines regulatory agencies are putting in place to help ensure the successful continuation of clinical research in these uncertain times.

Read More

How AI Is Helping Advance TB Research
Industry Insight

Technology Networks recently spoke with Dr Gillian Beamer, a pathologist and assistant professor at Tufts University and Thomas Westerling-Bui, Director, Scientific Strategy and Business Development at Aiforia, to learn how the implementation of a cloud-based platform is helping to advance scientific research on Mycobacterium tuberculosis.

Read More

Coronavirus and the Need To Go Beyond Testing in a Pandemic
Industry Insight

Technology Networks spoke to Phil Groom, commercial director of Bond Digital Health, about the need to go beyond testing in the COVID-19 pandemic, and why data capture is the key to pandemic preparedness and tackling future outbreaks.

Read More

Companion Diagnostic Will Support NSCLC Clinical Trials
Industry Insight

To learn more about some of the ways that companion diagnostics can benefit oncology patients, Technology Networks spoke to Dr Luca Quagliata, Global Director of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific.

Read More

 
Advertisement